CINECA IRIS Institutional Research Information System

FERRERO, Ivana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.407
EU - Europa 1.728
AS - Asia 1.237
SA - Sud America 39
AF - Africa 14
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.344
CN - Cina 607
IT - Italia 544
SG - Singapore 212
IE - Irlanda 194
DE - Germania 175
SE - Svezia 167
FI - Finlandia 123
UA - Ucraina 122
FR - Francia 117
KR - Corea 93
GB - Regno Unito 77
VN - Vietnam 73
JP - Giappone 69
PL - Polonia 64
CA - Canada 54
IN - India 37
ID - Indonesia 29
BR - Brasile 24
BE - Belgio 21
IR - Iran 20
AT - Austria 19
HK - Hong Kong 18
NL - Olanda 18
TW - Taiwan 18
TR - Turchia 15
NO - Norvegia 14
AU - Australia 13
ES - Italia 13
BG - Bulgaria 10
MY - Malesia 10
BY - Bielorussia 8
CL - Cile 8
PT - Portogallo 8
TH - Thailandia 8
MX - Messico 7
SN - Senegal 7
BD - Bangladesh 6
CZ - Repubblica Ceca 6
IL - Israele 6
PH - Filippine 6
CO - Colombia 5
RU - Federazione Russa 5
CH - Svizzera 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
HU - Ungheria 3
RO - Romania 3
SI - Slovenia 3
EU - Europa 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NG - Nigeria 2
AM - Armenia 1
AR - Argentina 1
EG - Egitto 1
GR - Grecia 1
KE - Kenya 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MQ - Martinica 1
PA - Panama 1
SC - Seychelles 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 6.440
Salva come PNG Salva come JPEG
Città #
Chandler 389
Beijing 330
Fairfield 303
Ashburn 203
Dublin 188
Torino 178
Houston 169
Singapore 167
Woodbridge 155
Ann Arbor 139
Wilmington 132
Seattle 130
Cambridge 101
Jacksonville 95
Santa Clara 82
Villeurbanne 73
Medford 71
Nyköping 65
Pisa 62
Columbus 60
Princeton 60
Dearborn 57
Warsaw 56
Dong Ket 51
Milan 50
Turin 39
Guangzhou 35
Fremont 34
Redwood City 33
Ottawa 31
Shanghai 31
Jakarta 28
Boston 22
Nanjing 21
San Diego 18
San Mateo 17
Brussels 15
Taipei 14
Vienna 14
New York 13
Zhengzhou 13
Boardman 12
Stavanger 12
Toronto 12
Düsseldorf 11
Helsinki 10
Los Angeles 10
Munich 10
Norwalk 9
Phoenix 9
Xian 9
Wuhan 8
Hangzhou 7
London 7
Tianjin 7
Buffalo 6
Chicago 6
Detroit 6
Dhaka 6
Galway 6
Hefei 6
Kuala Lumpur 6
Padova 6
Pavia 6
Santiago 6
Silver Spring 6
Washington 6
Buk-gu 5
Genova 5
Grafing 5
Groningen 5
Jinan 5
Kunming 5
Malo 5
Philadelphia 5
Pozzolo Formigaro 5
Rome 5
San Antonio 5
Tokyo 5
Verona 5
Central 4
Curitiba 4
Delft 4
Falkenstein 4
Heidelberg 4
Istanbul 4
Kagoshima 4
Montréal 4
Mumbai 4
Nuremberg 4
Paris 4
Prague 4
Prineville 4
Reims 4
Seoul 4
Shenyang 4
Shinjuku 4
Auburn Hills 3
Bangkok 3
Bologna 3
Totale 4.091
Salva come PNG Salva come JPEG
Nome #
Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application 564
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 355
Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. 346
Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions. 255
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. 196
Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. 189
High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines 187
Mesenchymal stem cells in Amyotrophic Lateral Sclerosis 162
Validation of analytical methods in compliance with good manufacturing practice: A practical approach 147
Myogenic potential of whole bone marrow mesenchymal stem cells in vitro and in vivo for usage in urinary incontinence. 147
Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. 135
Stem cell therapy applications in amyotrophic lateral sclerosis 133
Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity 133
Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use 124
Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study 124
Stem cell treatment in Amyotrophic Lateral Sclerosis. 123
COMPARING THE IMMUNOREGULATORY EFFECTS OF MESENCHYMAL STEM CELLS ISOALTED FROM BONE MARROW, PLACENTA AND AMNIOTIC FLUID 122
null 116
Analysis of Mesenchymal Stromal Cell Engraftment After Allogeneic HSCT in Pediatric Patients: A Large Multicenter Study 110
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors 103
Intrabone cord blood hematopoietic stem cell transplantation in a subset of very high-risk pediatric patients: a safety and feasibility pilot study. 99
Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. 97
Inactivated GMP-compliant human platelet lysate for clinical-scale expansion of mesenchymal stem cells. 97
The activity of STI571 in human osteosarcoma cells. 96
Mesenchymal stem cell chimerism following HSCT 94
Expansion of mesenchymal stem cells isolated from paediatric and adult donor bone marrow 92
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. 91
Adult Stem cells and neurodegenerative diseases 88
Inactivated human platelet lysate is a new method to censure safer GMP-compliant MSC production. 87
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients 86
PDGF-BB as mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 86
High-dose thiotepa and etoposide in children with poor-prognosis brain tumors 84
[The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects] 82
PDGF-BB is an effective mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 81
Engraftment of bone marrow – derived human mesenchymal stem cells in normal and injured liver of NOD/SCID mice 81
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential 81
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells 76
Stem cell transplantation in amyotrophic lateral sclerosis patients 74
Effect of in vitro exposure of corticosteroid drugs, conventionally used in AMD treatment, on mesenchymal stem cells 74
Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions 70
Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report. 69
null 67
Mesenchymal stem cells isolated from amniotic fluid differentiate in neural cells 65
null 64
Amyotrophic lateral sclerosis:What goals for cell therapy? 63
Mesenchymal Stem Cell Manufacturing for Clinical Use 62
Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types 60
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. 60
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy 50
STEM CELL TRANSPLANTATION IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS 49
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis 48
Differential expression of transforming growth factors-beta1, -beta2 and -beta3in human colon carcinoma. 48
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions 45
null 44
Validation of analytical methods in GMP: The disposable Fast Read 102® device, an alternative practical approach for cell counting 40
Stem cells in amyotrophic lateral sclerosis: state of the art 39
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential. 38
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers 34
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells 32
Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system 31
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo‐Secretome Isolated by Ultrafiltration 31
State of the Art and New Trends from the 2022 Gism Annual Meeting 27
Mesenchymal stem cells for ALS patients 27
GMP compliant isolation and expansion of MSCs with inactivated human platelet lysate 27
Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients 22
A New Paclitaxel Formulation Based on Secretome Isolated from Mesenchymal Stem Cells Shows a Significant Cytotoxic Effect on Osteosarcoma Cell Lines 21
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma 17
Validation of the media fill method for Cytokine-Induced killer cells manufacturing process 15
State of the Art and New Trends from the Second International StemNet Meeting 7
The Determination of Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions 2
Totale 6.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.045
article - articoli 0
book - libri 0
conference - conferenze 3.976
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.021
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020651 0 0 0 0 48 114 100 58 73 133 69 56
2020/20211.005 78 196 86 34 94 64 49 69 54 70 69 142
2021/2022785 42 35 27 65 29 47 49 63 35 73 167 153
2022/20231.053 99 81 23 109 100 278 73 55 127 20 52 36
2023/2024566 51 99 34 42 52 69 29 42 6 31 57 54
2024/2025498 15 74 98 126 185 0 0 0 0 0 0 0
Totale 6.691